Photo from academic.microsoft.com
Psoriasis is an inflammatory skin disease with an important disease burden worldwide and its treatment includes systemic therapies which have advanced over time to target specific immune cytokines such as… Click to show full abstract
Psoriasis is an inflammatory skin disease with an important disease burden worldwide and its treatment includes systemic therapies which have advanced over time to target specific immune cytokines such as interleukin‐17. The main objective of this study was to compare the relative efficacy of brodalumab, ixekizumab and secukinumab (three anti‐interleukin‐17 drugs) through adjusted indirect treatment comparisons (ITCs).
Keywords:
interleukin targeted;
targeted biological;
comparison anti;
indirect comparison;
psoriasis;
anti interleukin
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!